Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
6-Benzothiazolemethanamine dihydrochloride serves as a drug intermediate in the synthesis of diverse bioactive compounds. It plays a crucial role in the development of pharmaceuticals and facilitates the exploration of novel therapeutic agents. This reagent is valuable for researchers focused on medicinal chemistry and drug development applications. -
Drug Intermediate
(R)-Tetrahydrofuran-2-yl-methylamine is a synthetic intermediate that serves a critical role in pharmaceutical synthesis. Its unique structural properties facilitate the development of biologically active compounds. This reagent is valuable in research applications focusing on the synthesis of various therapeutic agents. -
Drug Intermediate
5-Benzyl-5-azaspiro[2.4]heptane-4,7-dione serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the development of novel therapeutic agents by providing a modular scaffold for further chemical modifications. Its unique structure is advantageous in medicinal chemistry, particularly in the exploration of biological activities pertinent to drug discovery. -
Drug Impurity
Methyl phenyl sulfone is a sulfone compound often identified as a drug impurity in pharmaceutical formulations. It can affect drug stability and bioavailability, making it significant in analytical chemistry and quality control. Researchers utilize this reagent to assess purity in drug synthesis and to evaluate the potential impact of impurities on pharmacological profiles. -
Drug Intermediate
1-(3-Chloropropyl)-3-(trifluoromethyl)benzene serves as a crucial drug intermediate in the synthesis of a variety of active pharmaceutical ingredients. Its unique structural features and reactivity make it valuable for medicinal chemistry applications, particularly in the development of compounds targeting specific biological pathways. This reagent is essential for researchers focusing on the synthesis and functional evaluation of novel therapeutic agents. -
Drug Impurity
Tofacitinib impurity 3 is a known impurity of the JAK1/3 inhibitor Tofacitinib. It is primarily utilized for assessing the purity and quality of Tofacitinib in pharmaceutical formulations. This impurity serves as a valuable reference standard in the development and analysis of therapeutic agents targeting immune-mediated disorders. -
Drug Intermediate
1-(6-Aminonaphthalen-2-yl)ethan-1-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structural properties facilitate the development of compounds with potential therapeutic applications. This reagent is particularly valuable in medicinal chemistry for the design and synthesis of novel bioactive molecules. -
Drug Intermediate
(R)-Ethyl 5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate serves as a versatile drug intermediate in the synthesis of diverse bioactive compounds. Its unique structural characteristics facilitate the development of indole derivatives and other pharmacologically relevant agents. This compound is valuable for researchers engaged in medicinal chemistry and drug discovery efforts. -
Drug Intermediate
(5-Amino-2-butylbenzofuran-3-yl)(4-(3-(dibutylamino)propoxy)phenyl)methanone serves as a critical drug intermediate in the synthesis of diverse bioactive compounds, particularly in the development of antiarrhythmic agents. This compound plays a significant role in facilitating the preparation and optimization of pharmacologically relevant molecules for cardiac research. Its functionalities enable researchers to explore novel therapeutic strategies in the treatment of atrial fibrillation and other cardiovascular conditions. -
Drug Intermediate
3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol acts as a versatile drug intermediate in organic synthesis. This compound facilitates the development of various biologically active molecules, making it an important building block in pharmaceutical research. Its unique structural features contribute to its utility in creating complex compounds for therapeutic applications. -
Drug Impurity
Metformin impurity 1 is a known impurity associated with the antidiabetic agent Metformin. This compound is important for quality control and regulatory compliance in pharmaceutical research, particularly in the analysis of drug formulations. Its presence and characterization are critical for ensuring the purity and efficacy of Metformin-containing products. -
Drug Intermediate
2-(Naphthalen-2-yl)acetonitrile is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. Its structural properties make it conducive for research applications focused on the development of therapeutic compounds. Researchers leverage this reagent for its role in facilitating complex chemical reactions integral to drug discovery and development. -
Drug Intermediate
(2S,4S)-1-((S)-2-Amino-3,3-Dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride is a specialized drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. It serves as a critical building block in medicinal chemistry, facilitating the development of compounds with potential therapeutic applications. This reagent is essential for researchers engaging in drug development and optimization processes. -
Drug Intermediate
3-Hydroxy-2-methylpyridine serves as a critical drug intermediate in the synthesis of pyrimidines. It exhibits potential as a corrosion inhibitor, making it valuable in various industrial applications. Its role in organic synthesis and material protection highlights its importance in pharmaceutical and chemical research. -
Drug Intermediate
tert-Butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. Its pyrazole ring structure and piperazine moiety provide essential building blocks for the development of novel therapeutic agents. This reagent is particularly relevant in pharmaceutical research for generating compounds targeting various biological pathways. -
Drug Intermediate
4-(2-Chloro-4-fluorophenyl)butanoic acid serves as a crucial drug intermediate in the synthesis of various bioactive compounds. Its structural features facilitate the development of pharmaceuticals targeting a range of therapeutic areas, allowing for the exploration of new drug candidates. This reagent is essential for researchers engaged in medicinal chemistry and compound development. -
Drug Intermediate
(S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine serves as a critical drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural features facilitate the development of agents with potential therapeutic applications. This compound is useful in medicinal chemistry for generating novel derivatives aimed at enhancing pharmacological properties. -
Drug Intermediate
Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate is a key drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. This compound plays a significant role in the development and production of therapeutic agents, contributing to various pharmacological activities. Its structural characteristics facilitate research applications in medicinal chemistry and drug discovery processes. -
Drug Intermediate
rel-(2R,3R)-2-Phenylpiperidin-3-amine dihydrochloride serves as a key intermediate in the synthesis of diverse pharmacologically active compounds. This compound is utilized in the development of various drug candidates, supporting research in medicinal chemistry and pharmaceutical formulation. Its structure allows for modifications that can lead to the discovery of novel therapeutic agents. -
Drug Intermediate
2-Amino-4-(4-pyridyl)-thiazole is a synthetic intermediate utilized in pharmaceutical synthesis. This compound exhibits potential in the development of various bioactive molecules, contributing to drug discovery efforts. Its unique structure allows for applications in creating targeted therapeutic agents in chemical research. -
Drug Impurity
Nintedanib impurity 4 is a known impurity of the multi-kinase inhibitor, Nintedanib, which primarily targets VEGFR, FGFR, and PDGFR pathways. This compound serves as a reference standard for the evaluation of drug purity and stability in pharmaceutical development. It is essential for researchers investigating the pharmacokinetics, safety, and regulatory compliance of Nintedanib in various biological assays and analytical methods. -
Drug Intermediate
3-(Dimethylamino)-1-(thiophen-2yl)propan-1-ol is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. This compound serves as a key building block, facilitating the development of therapeutic agents targeting various biological pathways. Its unique molecular structure enhances its applicability in medicinal chemistry research and drug development efforts. -
Drug Intermediate
(2S,4S)-1-(tert-Butoxycarbonyl)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxylic acid serves as a versatile drug intermediate in the synthesis of active pharmaceutical ingredients. This compound features a unique structure that facilitates the development of pharmacologically relevant agents. It is particularly useful in medicinal chemistry for generating compounds with potential therapeutic applications. -
Drug Intermediate
(2R,7aS)-Isopropyl 2-fluorohexahydro-1H-pyrrolizine-7a-carboxylate serves as a crucial drug intermediate in the synthesis of diverse biologically active compounds. Its unique structure enables its application in the production of potential therapeutics in various research contexts. This compound is integral for advancing drug discovery and development processes. -
Drug Intermediate
5-(Piperazin-1-yl)isoquinoline hydrochloride is an important drug intermediate utilized in the synthesis of various pharmacologically active compounds. This compound facilitates the introduction of isoquinoline structures, enhancing the biological activity of the final products. Its applications extend to medicinal chemistry, specifically in the development of novel therapeutic agents. -
Drug Intermediate
4-Methyl-2,3-dihydrocyclopenta[b]indol-1(4H)-one is a versatile drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical ingredients. This compound serves as a crucial building block in the development of various bioactive molecules, enabling researchers to explore its potential in pharmacological applications. Its unique structure and reactivity make it an important component in medicinal chemistry projects. -
Drug Intermediate
3-(Prop-2-yn-1-yloxy)aniline hydrochloride serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique alkyne functional group enables reactivity in coupling reactions, making it suitable for the development of complex molecular architectures. This compound is valuable in medicinal chemistry research, particularly in the design and optimization of new therapeutic agents. -
Drug Impurity
Apixaban impurity 41 is a known impurity associated with Apixaban, a direct factor Xa inhibitor. This compound is utilized in the pharmaceutical research setting to assess the purity and quality of Apixaban formulations. Its characterization is crucial for regulatory compliance and ensuring the therapeutic efficacy of Apixaban in clinical applications. -
Drug Intermediate
2-Amino-4-fluoropyridine is a key drug intermediate utilized in the synthesis of reversible-covalent fibroblast growth factor receptor 4 (FGFR4) inhibitors. This compound plays a significant role in medicinal chemistry research, particularly in the development of targeted therapies for cancer and other diseases associated with FGFR4 dysregulation. Its unique fluorinated pyridine structure enhances its efficacy in drug development processes. -
Drug Intermediate
BIBR 1087 SE is a key intermediate metabolite of dabigatran etexilate, functioning primarily as a reversible direct thrombin inhibitor. This compound plays a significant role in anticoagulant research, facilitating studies on blood coagulation pathways and thrombotic disorders. Its utilization in drug development is valuable for the creation of novel therapeutic agents targeting thrombin. -
Drug Intermediate
3,4-Difluoronitrobenzene is a versatile drug intermediate primarily utilized in the synthesis of oxazolidone antibiotics. Its unique structure allows for the modification and development of various pharmaceutical compounds, contributing to the advancement of antimicrobial therapies. This reagent serves as a valuable tool in medicinal chemistry research aimed at addressing bacterial infections. -
Drug Intermediate
Pyridine-3,5-dicarboxylic acid serves as a drug intermediate, primarily utilized in the synthesis of novel metal-organic framework materials. Its structural properties facilitate the formation of coordination complexes, making it valuable for applications in pharmaceuticals and materials science. This compound is essential for studies focusing on drug development and the creation of advanced functional materials. -
Drug Intermediate
Methyl 1H-pyrrole-2-carboxylate serves as a versatile drug intermediate, primarily functioning as an acyl donor. This compound is amenable to tranesterification reactions with a variety of alcohols, facilitating the synthesis of diverse pyrrolidine derivatives. Its applications in medicinal chemistry make it a valuable building block in the development of pharmaceutical compounds. -
Drug Intermediate
2,6-Dichloropurine is a pharmaceutical intermediate primarily utilized in the synthesis of various drug candidates. This compound plays a key role in the development of phosphodiesterase (PDE) inhibitors, human A3 adenosine receptor antagonists, and cyclin-dependent kinase (CDK) inhibitors. Its versatile chemical structure makes it a valuable reagent in biomedical research and pharmaceutical development. -
Drug Intermediate
2-Pyridinecarbohydrazide is a versatile building block commonly employed as a drug intermediate in synthetic processes. Its structure allows for diverse modifications, facilitating the development of biologically active compounds. Applications include the synthesis of pharmaceuticals and agrochemicals, making it an essential reagent in chemical research and development. -
Drug Intermediate
5-Bromonicotinic acid serves as a valuable pharmaceutical intermediate for the synthesis of 5-aryloyl nicotinic acid derivatives. It exhibits favorable drug-like properties, including high oral bioavailability and low toxicity, as indicated by molecular docking predictions. Notably, 5-Bromonicotinic acid demonstrates significant binding affinity to hepatitis virus proteins, with binding energies ranging from -4.7 to -5.3 kcal/mol, making it relevant for antiviral research applications. -
Drug Intermediate
4-Nitropyrazole is a nitrogen-containing heterocyclic compound that serves as a crucial drug intermediate. This compound can be synthesized into various derivatives, including antibiotics, antifungal, and antiviral agents featuring pyrazole rings. Additionally, 4-Nitropyrazole can be utilized in C-H activation reactions to develop LRRK2 inhibitors, which play a significant role in Parkinson's disease research. -
Drug Impurity
Olanzapine impurity 2 hydrochloride is a known impurity of the antipsychotic compound, Olanzapine hydrochloride. This reagent plays a critical role in drug quality control and formulation research, facilitating the assessment of purity and stability in pharmaceutical preparations. Its examination is essential for regulatory compliance and the development of safer therapeutic agents. -
Drug Intermediate
3beta,6alpha,17beta-Trihydroxy-5alpha-androstane serves as a crucial drug intermediate in the synthesis of various biologically active compounds. Its structural characteristics enable the modification and development of steroid-based therapeutics. This compound is commonly utilized in pharmaceutical research focused on androgenic and anabolic effects. -
Drug Impurity
Methyl 2-tert-Butyloxycarbonylaminoacrylate is characterized as a drug impurity that may emerge during the synthesis of pharmaceutical compounds. This compound serves as a key reference standard in analytical chemistry, aiding in the identification and quantification of related substances in drug development. Its presence is relevant for ensuring the purity and safety profiles of therapeutic agents. -
Drug Intermediate
Boc-tyr(bzl)-aldehyde is a versatile drug intermediate primarily utilized in the synthesis of a variety of active pharmaceutical compounds. Its structure features a tert-butyl carbamate group, enabling selective transformations in organic chemistry. This reagent is essential for researchers developing novel therapeutic agents that require precise chemical modifications. -
Drug Intermediate
4-Methyl-1,3-benzodioxole-5-carboxylic acid serves as a crucial drug intermediate in the synthesis of various bioactive compounds. This versatile chemical structure facilitates the development of pharmaceuticals by providing a key building block for further modifications. It is particularly relevant in the fields of medicinal chemistry and drug discovery, where it supports the design of novel therapeutic agents. -
Drug Intermediate
(2S,3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride serves as an essential drug intermediate in the synthesis of diverse bioactive compounds. Its unique structural properties facilitate the development of therapeutic agents, making it valuable in pharmaceutical research and development. This reagent is particularly useful for studies involving antiviral drug synthesis and related applications. -
Drug Intermediate
2-(Ethoxycarbonyl)-3-methylbutanoic acid is a versatile drug intermediate primarily utilized in the synthesis of various active pharmaceutical compounds. This reagent facilitates the incorporation of essential functional groups in complex organic molecules, serving as a key building block in drug development. Its application is significant in both medicinal chemistry and organic synthesis, contributing to the advancement of therapeutic agents. -
Drug Intermediate
2,6-Diisopropyl-p-benzoquinone is a versatile drug intermediate that is utilized in the synthesis of Geldanamycin. This compound serves as an important building block in the development of novel therapeutic agents, particularly those targeting heat shock proteins. Its relevance in medicinal chemistry makes it a valuable component for researchers exploring anticancer strategies and drug development pathways. -
Drug Intermediate
2-Chloro-1-(5-methoxy-1H-indol-3-yl)-ethanone is a versatile drug intermediate utilized in the synthesis of a range of bioactive compounds. This reagent serves as a key building block in medicinal chemistry, facilitating the development of novel pharmaceuticals and therapeutic agents. Its structure and reactivity make it suitable for applications in drug discovery and chemical biology research. -
Drug Intermediate
2,2,2-Trifluoro-1-(4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethanone is a crucial drug intermediate involved in the synthesis of multiple active pharmaceutical compounds. This reagent serves as an essential starting material for the production of Odanacatib and related therapeutic agents. Its key applications include drug development and medicinal chemistry research, facilitating the exploration of novel treatments. -
Drug Intermediate
tert-Butyl (1S)-3-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate serves as a crucial drug intermediate in the synthesis of numerous active pharmaceutical compounds. This compound is utilized to facilitate the development of diverse medicinal agents, enabling research into novel therapeutic options. Its structural properties make it valuable for applications in organic synthesis and medicinal chemistry. -
Drug Intermediate
(R)-Octahydro-pyrido[1,2-A]pyrazine functions as a drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. Its unique structural properties make it a valuable building block in organic synthesis and medicinal chemistry applications. This reagent is instrumental in advancing drug discovery efforts and the development of novel therapeutics. -
Drug Intermediate
(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate serves as a crucial drug intermediate in pharmaceutical synthesis. This compound is pivotal in the preparation of diverse active pharmaceutical ingredients, facilitating the development of therapeutic agents with enhanced efficacy. Its unique structural properties make it a valuable reagent in organic synthesis targeting steroid derivatives and related compounds.
